Literature DB >> 26251823

Treatment of Binge Eating Disorder.

Scott Crow1.   

Abstract

Binge eating disorder is a common eating disorder that recently has received increasing attention. Goals in treating binge eating disorder typically include controlling binge eating and diminishing excess body weight. A variety of treatment approaches have been used, including diet/lifestyle modification, psychotherapy, and pharmacologic treatment. Diet and lifestyle interventions are somewhat effective in diminishing the binge eating behavior and lead to modest weight loss, but the weight effects are limited and not typically lasting. A number of psychotherapies have been shown to be beneficial, mostly for stopping binge eating, and tend to show little impact on weight loss. Numerous pharmacologic interventions have been developed, with the focus on antidepressants (used for their anti-binge eating effects) and weight loss drugs. Both have been shown to be helpful but again, for antidepressants, bringing about lasting weight loss appears to be difficult. The most effective approach to treating binge eating disorder (if available) is likely psychotherapy combined with medication management as indicated.

Entities:  

Keywords:  Anti-depressants; Behavioral weight loss; Binge eating; Binge eating disorder; Cognitive behavioral therapy; Eating disorder; Obesity; Weight loss

Year:  2014        PMID: 26251823      PMCID: PMC4523274          DOI: 10.1007/s40501-014-0023-4

Source DB:  PubMed          Journal:  Curr Treat Options Psychiatry


  22 in total

1.  Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.

Authors:  Susan L McElroy; James I Hudson; Julie A Capece; Karen Beyers; Alan C Fisher; Norman R Rosenthal
Journal:  Biol Psychiatry       Date:  2007-01-29       Impact factor: 13.382

2.  High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial.

Authors:  Anna I Guerdjikova; Susan L McElroy; Renu Kotwal; Jeffrey A Welge; Erik Nelson; Katie Lake; David D' Alessio; Paul E Keck; James I Hudson
Journal:  Hum Psychopharmacol       Date:  2008-01       Impact factor: 1.672

3.  Cognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-up.

Authors:  Michael J Devlin; Juli A Goldfein; Eva Petkova; Linxu Liu; B Timothy Walsh
Journal:  Obesity (Silver Spring)       Date:  2007-07       Impact factor: 5.002

4.  Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial.

Authors:  Anna I Guerdjikova; Susan L McElroy; Erin L Winstanley; Eric B Nelson; Nicole Mori; Jessica McCoy; Paul E Keck; James I Hudson
Journal:  Int J Eat Disord       Date:  2011-07-08       Impact factor: 4.861

5.  Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trial.

Authors:  Carlos M Grilo; Robin M Masheb; Stacey L Salant
Journal:  Biol Psychiatry       Date:  2005-05-15       Impact factor: 13.382

6.  Effect of orlistat in obese patients with binge eating disorder.

Authors:  Alain Golay; Anne Laurent-Jaccard; Frank Habicht; Jean-Pierre Gachoud; Mireille Chabloz; Anne Kammer; Yves Schutz
Journal:  Obes Res       Date:  2005-10

7.  Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison.

Authors:  Carlos M Grilo; Robin M Masheb; G Terence Wilson
Journal:  Biol Psychiatry       Date:  2005-02-01       Impact factor: 13.382

8.  Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.

Authors:  Susan L McElroy; James I Hudson; Shishuka Malhotra; Jeffrey A Welge; Erik B Nelson; Paul E Keck
Journal:  J Clin Psychiatry       Date:  2003-07       Impact factor: 4.384

9.  Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.

Authors:  Susan L McElroy; Lesley M Arnold; Nathan A Shapira; Paul E Keck; Norman R Rosenthal; M Rezaul Karim; Marc Kamin; James I Hudson
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112

10.  Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study.

Authors:  Denise E Wilfley; Scott J Crow; James I Hudson; James E Mitchell; Robert I Berkowitz; Vicky Blakesley; B Timothy Walsh
Journal:  Am J Psychiatry       Date:  2007-12-03       Impact factor: 18.112

View more
  2 in total

1.  Correlates of interpersonal emotion regulation problems in Loss of Control eating (LOC) in youth: study protocol of the combined online and App based questionnaire, laboratory and randomized controlled online intervention i-BEAT trial.

Authors:  Simone Munsch; Felicitas Forrer; Adrian Naas; Verena Mueller; Marius Rubo; Fouad Hannoun; Elena Mugellini
Journal:  BMC Psychol       Date:  2021-12-11

2.  Retention, engagement, and binge-eating outcomes: Evaluating feasibility of the Binge-Eating Genetics Initiative study.

Authors:  Rachael E Flatt; Laura M Thornton; Tosha Smith; Hannah Mitchell; Stuart Argue; Brian R W Baucom; Pascal R Deboeck; Colin Adamo; Robyn E Kilshaw; Qinxin Shi; Jenna Tregarthen; Jonathan E Butner; Cynthia M Bulik
Journal:  Int J Eat Disord       Date:  2022-05-02       Impact factor: 5.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.